NDC1

Nucleoporin NDC1 · Q9BTX1 · NDC1 on Sugi Atlas →

0 patent compounds predicted against NDC1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NDC1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) PHASE3COMPLETED
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma PHASE2COMPLETED
Capecitabine and Temozolomide for Neuroendocrine Cancers PHASE2COMPLETED
BN201 SAD MAD Study in Healthy Subjects PHASE1COMPLETED
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk nanNOT_YET_RECRUITING
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) nanRECRUITING
Characteristics of Nondystrophic Myotonias nanCOMPLETED
The Contribution of Optical Mapping to the Characterization of Chromosomal Rearrangements in Patients With Neurodevelopmental Disorders nanRECRUITING
The Natural History of Mitochondrial Diseases nanRECRUITING
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Natural History in Primary Mitochondrial Myopathies nanRECRUITING
Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells nanRECRUITING
Genetics of Neonatal Encephalopathy and Related Disorders nanRECRUITING
Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection nanCOMPLETED
Prospective Cohort Study of Neurogenetic Diseases nanRECRUITING
Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS nanRECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
GDF-15 as a Biomarker for Mitochondrial Disease nanCOMPLETED
Diagnostic Research in Patients With Rare Diseases - Solving the Unsolved Rare Diseases nanUNKNOWN
Nicotinamide Riboside and Mitochondrial Biogenesis nanCOMPLETED
The Roles of Neutrophil Elastase in Lung Cancer nanUNKNOWN
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Mitochondrial DNA in Peripheral Blood Leukocytes nanNOT_YET_RECRUITING
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders nanRECRUITING
Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip nanCOMPLETED
Survey on Supplement Use in Mitochondrial Disease nanCOMPLETED
Whole Exome Sequencing in Prenatal Diagnosis of Agenesis of the Corpus Callosum nanCOMPLETED
MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases nanRECRUITING
Clinical Study of Hydroxytyrosol (HT) in Mitochondrial Diseases nanCOMPLETED
RFC1 Natural History Study nanRECRUITING
Predisposition Genes in Monogenic Diabetes (DIAMONO) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a NDC1 binder may also engage these)

ProteinNameSimilarity
Q5RBY5 1.000 Q5RBY5 →
Q8VCB1 1.000 Q8VCB1 →
Q6AXN4 1.000 Q6AXN4 →
Q7SZC5 0.988 Q7SZC5 →
Q6AX31 0.978 Q6AX31 →
Q7ZW11 0.975 Q7ZW11 →
Q8IZQ1 0.973 Q8IZQ1 →
A7MBC7 0.973 A7MBC7 →
Q7TMY8 0.973 Q7TMY8 →
Q66H44 0.972 Q66H44 →
Q8CB19 0.971 Q8CB19 →
Q9GZU3 0.971 Q9GZU3 →
Q5RFD3 0.971 Q5RFD3 →
Q5XPI4 0.971 Q5XPI4 →
Q08CZ0 0.971 Q08CZ0 →
Q9D486 0.971 Q9D486 →
O14524 0.971 O14524 →
Q9DBN1 0.971 Q9DBN1 →
A2T1U1 0.971 A2T1U1 →
A1L3F5 0.970 A1L3F5 →
Q7L1W4 0.970 Q7L1W4 →
A8C750 0.970 A8C750 →
Q8TAP6 0.970 Q8TAP6 →
Q5ZKN3 0.970 Q5ZKN3 →
Q810L4 0.970 Q810L4 →
Q5RDB4 0.970 Q5RDB4 →
Q4QQS8 0.970 Q4QQS8 →
Q5HYA8 0.970 Q5HYA8 →
Q17QW2 0.970 Q17QW2 →
A0A0D3MU35 0.969 A0A0D3MU35 →